Calvo-Henríquez Christian, Ruano-Ravina Alberto, Vaamonde Pedro, Martínez-Capoccioni Gabriel, Martín-Martín Carlos
1 Service of Otolaryngology, Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain.
2 Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain.
Otolaryngol Head Neck Surg. 2017 Sep;157(3):385-391. doi: 10.1177/0194599817709430. Epub 2017 Jun 6.
Objective Laryngopharyngeal reflux (LPR) is a common illness of otolaryngology visits. Over the past few years, pepsin has become a promising marker of LPR. The objective of the present research is to analyze the existing literature using pepsin as a diagnostic tool of LPR through a systematic review. Data Sources PubMed (Medline), Trip Database, Cochrane Library, EMBASE, SUMsearch, and Web of Science. Review Methods The outcome assessed was the presence of pepsin in LPR patients. We included articles in which pepsin was studied in LPR patients (clinically suspected or with confirmed diagnosis). Studies with no control group, comparison group, and/or a sample size lower than 20 patients were excluded. Results Twelve studies were included. All included studies, with the exception of 2, found statistically significant differences for pepsin in cases compared with healthy controls. Conclusion Pepsin might be a reliable marker in LPR patients, although questions remain about optimal timing, location, nature, and threshold values for pepsin testing. Future investigations are necessary to clarify the best method to use pepsin in the diagnostic process of LPR.
目的 喉咽反流(LPR)是耳鼻喉科门诊常见疾病。在过去几年中,胃蛋白酶已成为一种有前景的LPR标志物。本研究的目的是通过系统评价,分析以胃蛋白酶作为LPR诊断工具的现有文献。
数据来源 PubMed(医学索引数据库)、Trip数据库、Cochrane图书馆、EMBASE、SUMsearch和科学引文索引数据库。
综述方法 评估的结果是LPR患者中胃蛋白酶的存在情况。我们纳入了对LPR患者(临床疑似或确诊)进行胃蛋白酶研究的文章。排除没有对照组、比较组和/或样本量少于20例患者的研究。
结果 纳入12项研究。除2项研究外,所有纳入研究均发现,与健康对照相比,病例组胃蛋白酶存在统计学显著差异。
结论 胃蛋白酶可能是LPR患者的可靠标志物,尽管关于胃蛋白酶检测的最佳时间、部位、性质和阈值仍存在疑问。未来有必要进行研究,以阐明在LPR诊断过程中使用胃蛋白酶的最佳方法。